Duchenne Ireland is delighted to announce that is has become a member of the Treat-NMD network of excellence for Neuromuscular Diseases around the world.

TREAT-NMD is a network for people with neuromuscular diseases and professionals working in the field. It aims to advance diagnosis and care and develop new treatments for the benefit of patients and families, working closely with scientists, healthcare professionals, the pharmaceutical industry and patient groups around the world.

Duchenne Ireland is committed to fostering the details outlined in the Treat-NMD Member Charter within Ireland and wherever we represent Children with Duchenne internationally in the aim of facilitating change in the natural course of Duchenne.

We look forward to all of our supporters continued help to ensure we have the resources to continue reaching out to similar international networks of excellence and researchers to drive for effective therapies for Duchenne.